Diagnostic and therapeutic advances have led to much greater awareness of transthyretin cardiac amyloidosis (ATTR-CA). We aimed to characterize changes in the clinical phenotype of patients diagnosed with ATTR-CA over the past 20 years.

Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years

Porcari, Aldostefano;Sinagra, Gianfranco;
2022-01-01

Abstract

Diagnostic and therapeutic advances have led to much greater awareness of transthyretin cardiac amyloidosis (ATTR-CA). We aimed to characterize changes in the clinical phenotype of patients diagnosed with ATTR-CA over the past 20 years.
Pubblicato
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.060852
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698091/
File in questo prodotto:
File Dimensione Formato  
CIRCULATIONAHA.122.060852.pdf

accesso aperto

Tipologia: Documento in Versione Editoriale
Licenza: Creative commons
Dimensione 1.81 MB
Formato Adobe PDF
1.81 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/3033098
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? ND
social impact